安全网医院系统中全关节置换术前常规毒理学筛查与物质滥用治疗的应用价值
在 urban 三级安全网医院,723 例择期初次全髋或全膝关节置换患者接受尿毒理学筛查,19% 阳性,其中 42% 为意外阳性;阳性者需至少 3 个月术前咨询与治疗。校正年龄和 ASA 分级后,阳性组与阴性组在并发症、再入院和再手术风险上无显著差异。
要点
- 安全网医院全关节置换术前普遍毒理学筛查的意外阳性率为 42%。
- 阳性患者经至少 3 个月物质滥用治疗并延迟手术后,并发症风险与阴性患者无显著差异。
- 阳性组再入院 OR 0.14(95%CI 0.01-0.65,P=0.051),未达统计学显著。
核心结论
- 在安全网医院,全关节置换术前普遍毒理学筛查可发现具有临床意义的意外阳性率。
- 术前物质滥用治疗并至少延迟手术 3 个月,与阴性结果患者结局相当,可能改善弱势患者的照护与结局。
研究设计与样本
- 研究纳入 18 至 90 岁、在城市三级安全网医院拟行择期初次全关节置换的患者,接受尿毒理学筛查(阿片类、苯二氮䓬类、可卡因、巴比妥类、苯丙胺类)。
- 毒理学阳性患者需接受物质滥用专科医生至少 3 个月的术前咨询与治疗。
- 采用多变量分析比较毒理学阳性与阴性患者的并发症、再入院和再手术。
主要发现
- 2020 年 10 月至 2022 年 12 月共 723 例患者接受初次全关节置换,女性占 60%,平均年龄 61 岁。
- 19% 患者毒理学筛查阳性,其中 42% 为意外阳性结果。
- 校正年龄和 ASA 分级后,毒理学阳性组与阴性组相比,合计内科和外科并发症风险无显著差异(OR 0.67,95%CI 0.28-1.42,P=0.33)。
- 毒理学阳性组与阴性组相比,再入院风险无显著差异(OR 0.14,95%CI 0.01-0.65,P=0.051)。
- 毒理学阳性组与阴性组相比,再手术风险无显著差异(OR 0.28,95%CI 0.04-0.96,P=0.086)。
关键数值与推荐
- 毒理学筛查项目包括阿片类、苯二氮䓬类、可卡因、巴比妥类和苯丙胺类。
- 毒理学阳性患者需接受至少 3 个月的术前物质滥用专科咨询与治疗。
临床怎么用
- 作者认为,在安全网医院,全关节置换术前普遍毒理学筛查可发现具有临床意义的意外阳性率。
- 作者认为,术前物质滥用治疗并至少延迟手术 3 个月,与阴性结果患者结局相当,可能改善弱势患者的照护与结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative substance use disorder (SUD) is an independent risk factor for complications and readmissions following primary total joint arthroplasty (TJA) of the hip and knee. In the context of value-based care, access to care for those who have SUD is threatened. In health safety-net (HSN) hospitals, the incidence of SUD has increased. This study aimed to determine the effect of universal toxicology screening to identify patients who had SUD for optimization before TJA. We hypothesized there would be a high yield of unexpected positive results and that delaying surgery for SUD treatment results in complication rates comparable to those who do not have SUD. METHODS: Patients aged 18 to 90 years indicated for elective primary TJA at an urban, tertiary care HSN hospital underwent universal urine toxicology screening for opiates, benzodiazepines, cocaine, barbiturates, and amphetamines. Patients who had positive toxicology were required to undergo a minimum of 3 months of preoperative counseling and treatment by a SUD specialist. A multivariate analysis was performed to compare complications, readmissions, and reoperations for those who had positive versus negative tests. RESULTS: From October 2020 to December 2022, 723 patients underwent primary TJA, with 60% women and a mean age of 61 years. There were 19% who had a positive toxicology screen, of which 42% were unexpected positive results. Adjusting for age and American Society of Anesthesiologists class, patients who had a positive toxicology screen did not have an increased risk of aggregate medical and surgical complications (odds ratio) 0.67, 95% confidence interval [CI] 0.28 to 1.42, P = 0.33), readmission (odds ratio 0.14, 95% CI 0.01 to 0.65, P = 0.051), or reoperation (0.28, 95% CI 0.04 to 0.96, P = 0.086) in comparison to those who had negative tests. CONCLUSIONS: In an HSN setting, universal toxicology screening prior to TJA yields a clinically important rate of unexpected positive results. Preoperative SUD treatment with a minimum 3-month surgical delay was associated with outcomes comparable to those who had negative results and thus may improve care and outcomes for vulnerable patient populations.
引用
- Perez Menendez SH, Dienes E, Salavati S, et al. The Utility of Routine Toxicology Screening and Substance Misuse Treatment Before Total Joint Arthroplasty in a Safety Net Hospital System. J Arthroplasty. 2025. PMID: 40484057. doi:10.1016/j.arth.2025.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。